This deliverable of COST Action CA20121 (BenBedPhar) highlights the extensive collaborative scientific output generated by the network in the field of NRF2 biology, pharmacology, and translational applications. Since its launch, BenBedPhar has actively fostered cooperation among participating institutions, leading to a growing number of joint publications in high-impact, peer-reviewed international journals.
These studies collectively reflect the Action’s multidisciplinary approach, encompassing molecular mechanisms of NRF2 signaling, the identification and characterization of NRF2 modulators, the development of bioinformatics tools and databases, and the exploration of NRF2-based therapeutic strategies across multiple noncommunicable diseases.
BenBedPhar’s coordinated efforts have resulted in a dynamic publication portfolio, accessible through the network’s official website:
General Publications: https://benbedphar.org/publications/
Collaborative Publications: https://benbedphar.org/collaborative-publications/
Together, these outputs demonstrate the scientific productivity and impact of BenBedPhar, showcasing how European collaboration accelerates progress in NRF2-related translational research. The deliverable illustrates the Action’s success in connecting basic science with pharmacological innovation and reinforces its role as a key driver of excellence and knowledge dissemination in the NRF2 field.
